NCT06470711 Mapping of Electrical Properties in the Brain
| NCT ID | NCT06470711 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Malignant Glioma |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-09-13 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2024-09-13 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates imaging methods for monitoring neural and electrical activity in the brain for improving clinical diagnosis.
Eligibility Criteria
Inclusion Criteria: * Aim 1: normal healthy volunteers * Aim 2, 3, 4: participants included in IRB 16-002424, including those that have undergone surgical biopsy/resection for suspected or known glioma Exclusion Criteria: * Healthy volunteer unable to have an MRI
Contact & Investigator
Leland S. Hu, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06470711 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Malignant Glioma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06470711 currently recruiting?
Yes, NCT06470711 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT06470711 trial being conducted?
This trial is being conducted at Scottsdale, United States.
Who is sponsoring the NCT06470711 clinical trial?
NCT06470711 is sponsored by Mayo Clinic. The principal investigator is Leland S. Hu, MD at Mayo Clinic. The trial plans to enroll 120 participants.